Tay-Sachsova nemoc, varianta AB [Tay-Sachs Disease, AB Variant]

tematický
Termíny

aktivátor proteinu GM2 - nedostatek
deficit G(M2) aktivátorového proteinu
gangliosidóza GM2 - typ AB
gangliosidóza GM2 - varianta AB
nedostatek G(M2) aktivátorového proteinu
Tayova-Sachsova nemoc, typ AB

 

AB Variant Gangliosidosis GM2
AB Variant GM2-Gangliosidosis
Activator Deficiency GM2 Gangliosidosis
Activator-Deficient Tay-Sachs Disease
Deficiency Disease, GM2 Protein Activator
Gangliosidosis GM2, AB Variant
Gangliosidosis GM2, Type AB
GM2 Activator Deficiency
GM2 Activator Deficiency Disease
GM2 Gangliosidosis, Type AB
GM2 Protein Activator Deficiency Disease
GM2-Gangliosidosis, AB Variant
Hexosaminidase Activator Deficiency
Hexosaminidase Activator Protein Deficiency Disease

Perzistentní odkaz   https://www.medvik.cz/link/D049290
Definice

Progresivní neurodegenerativní porucha, která začíná svalovou slabostí, postupuje k náhlé reakci, retardaci a záchvatům. Projevuje se akumulací G(M2) gangliosidů v neuronech, která je způsobena nedostatkem funkce G(M2) aktivátorového proteinu. Označení varianty AB se týká zvýšení hexosaminidasy A a hexosaminidasy B v tkáních s nedostatkem G(M2) aktivátorového proteinu.

A progressive neurodegenerative disorder that begins with muscle weakness, then progresses to startle reaction, retardation and seizures. It is characterized by the accumulation of G(M2) GANGLIOSIDE in neurons that is caused by a lack of G(M2) ACTIVATOR PROTEIN function. The AB variant designation refers to the increase of both HEXOSAMINIDASE A and HEXOSAMINIDASE B in tissues that lack of G(M2) activator protein.

DUI
D049290 MeSH Prohlížeč
CUI
M0335225
Předchozí užití
Gangliosidoses (2000-2004)
Historická pozn.
2005(2000); use GANGLIOSIDOSES GM2 2000-2004
Veřejná pozn.
2005; see GANGLIOSIDOSES GM2 2000-2004

C Nemoci
C10.228.140 nemoci mozku 1 183
C10.228.140.163 metabolické nemoci mozku 85
C10.228.140.163.100.435.825 sfingolipidózy 12
C10.228.140.163.100.435.825.300 gangliosidóza 11
C10.228.140.163.100.435.825.300.300 gangliosidózy GM2 2
C10.228.140.163.100.435.825.300.300.249 Sandhoffova nemoc 1
C10.228.140.163.100.435.825.300.300.500 Tay-Sachsova nemoc 15
C10.228.140.163.100.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C16.320.565.189.435.825 sfingolipidózy 12
C16.320.565.189.435.825.300 gangliosidóza 11
C16.320.565.189.435.825.300.300 gangliosidózy GM2 2
C16.320.565.189.435.825.300.300.249 Sandhoffova nemoc 1
C16.320.565.189.435.825.300.300.500 Tay-Sachsova nemoc 15
C16.320.565.189.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C16.320.565.398.641 lipidózy 35
C16.320.565.398.641.803 sfingolipidózy 12
C16.320.565.398.641.803.350 gangliosidóza 11
C16.320.565.398.641.803.350.300 gangliosidózy GM2 2
C16.320.565.398.641.803.350.300.700 Sandhoffova nemoc 1
C16.320.565.398.641.803.350.300.850 Tay-Sachsova nemoc 15
C16.320.565.398.641.803.350.300.925 Tay-Sachsova nemoc, varianta AB
C16.320.565.595.554.825 sfingolipidózy 12
C16.320.565.595.554.825.300 gangliosidóza 11
C16.320.565.595.554.825.300.300 gangliosidózy GM2 2
C16.320.565.595.554.825.300.300.800 Sandhoffova nemoc 1
C16.320.565.595.554.825.300.300.840 Tay-Sachsova nemoc 15
C16.320.565.595.554.825.300.300.920 Tay-Sachsova nemoc, varianta AB
C18.452 metabolické nemoci 1 200
C18.452.132.100.435.825 sfingolipidózy 12
C18.452.132.100.435.825.300 gangliosidóza 11
C18.452.132.100.435.825.300.300 gangliosidózy GM2 2
C18.452.132.100.435.825.300.300.249 Sandhoffova nemoc 1
C18.452.132.100.435.825.300.300.500 Tay-Sachsova nemoc 15
C18.452.132.100.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C18.452.584.563.641 lipidózy 35
C18.452.584.563.641.803 sfingolipidózy 12
C18.452.584.563.641.803.350 gangliosidóza 11
C18.452.584.563.641.803.350.300 gangliosidózy GM2 2
C18.452.584.563.641.803.350.300.700 Sandhoffova nemoc 1
C18.452.584.563.641.803.350.300.850 Tay-Sachsova nemoc 15
C18.452.584.563.641.803.350.300.925 Tay-Sachsova nemoc, varianta AB
C18.452.648.189.435.825 sfingolipidózy 12
C18.452.648.189.435.825.300 gangliosidóza 11
C18.452.648.189.435.825.300.300 gangliosidózy GM2 2
C18.452.648.189.435.825.300.300.249 Sandhoffova nemoc 1
C18.452.648.189.435.825.300.300.500 Tay-Sachsova nemoc 15
C18.452.648.189.435.825.300.300.750 Tay-Sachsova nemoc, varianta AB
C18.452.648.398.641 lipidózy 35
C18.452.648.398.641.803 sfingolipidózy 12
C18.452.648.398.641.803.350 gangliosidóza 11
C18.452.648.398.641.803.350.300 gangliosidózy GM2 2
C18.452.648.398.641.803.350.300.700 Sandhoffova nemoc 1
C18.452.648.398.641.803.350.300.850 Tay-Sachsova nemoc 15
C18.452.648.398.641.803.350.300.925 Tay-Sachsova nemoc, varianta AB
C18.452.648.595.554.825 sfingolipidózy 12
C18.452.648.595.554.825.300 gangliosidóza 11
C18.452.648.595.554.825.300.300 gangliosidózy GM2 2
C18.452.648.595.554.825.300.300.800 Sandhoffova nemoc 1
C18.452.648.595.554.825.300.300.840 Tay-Sachsova nemoc 15
C18.452.648.595.554.825.300.300.920 Tay-Sachsova nemoc, varianta AB